Enlivex LTD. (ENLV) SEC Filings — 2024
22 SEC filings for Enlivex LTD. (ENLV) in 2024.
Filings
- Enlivex Therapeutics gets Israeli MoH approval for Phase I sepsis trial — 6-K · Dec 11, 2024
- Enlivex Therapeutics Reports Positive Phase I Data for Allocetra™ — 6-K · Dec 3, 2024
- Enlivex Therapeutics Files 6-K with Q3 Financials — 6-K · Nov 29, 2024
- Enlivex Therapeutics to Buy Up to $1M in Bitcoin — 6-K · Nov 20, 2024
- Enlivex Doses First Patient in Phase I Solid Tumor Trial — 6-K · Nov 14, 2024
- Enlivex Therapeutics LTD. SC 13G Filing — SC 13G · Nov 14, 2024
- Enlivex Therapeutics Enrolls First 10 Patients in Phase II Trial — 6-K · Nov 12, 2024
- Enlivex Therapeutics Holds 2024 Annual Shareholder Meeting — 6-K · Nov 8, 2024
- Enlivex Therapeutics 2024 Shareholder Meeting Fails Due to Lack of Quorum — 6-K · Oct 31, 2024
- Enlivex Therapeutics Secures Japanese Patent Allowance — 6-K · Oct 30, 2024
- Enlivex Therapeutics Gets Green Light for Phase II COVID-19 Trial — 6-K · Sep 26, 2024
- Enlivex Therapeutics Trial Continues After Positive DSMB Review — 6-K · Sep 24, 2024
- Enlivex Therapeutics Files September 2024 6-K Report — 6-K · Sep 11, 2024
- Enlivex Therapeutics Files 6-K with Financials — 6-K · Aug 30, 2024
- Enlivex Therapeutics Gets Green Light for Phase I Trial — 6-K · Jul 23, 2024
- Enlivex Doses First Patient in COVID-19 Trial — 6-K · Jun 24, 2024
- Enlivex Therapeutics to Host Investor Webinar — 6-K · Jun 20, 2024
- Enlivex Therapeutics Reports Positive Phase I/II Trial Data — 6-K · Jun 17, 2024
- Enlivex Therapeutics Files 6-K with Financial Updates — 6-K · Jun 14, 2024
- Enlivex Therapeutics Gets Green Light for COVID-19 Trial — 6-K · Jun 3, 2024
- Enlivex Therapeutics Enters Securities Purchase Agreement — 6-K · May 29, 2024
- Enlivex Therapeutics Secures $5M Private Placement — 6-K · May 28, 2024